IQVIA Holdings (IQV), a clinical research and healthcare intelligence provider, is highlighted as a stock to watch with a Zacks Rank #3 (Hold) and VGM Score of B. The company has a Momentum Style Score of B with shares up 0.4% over the past four weeks. One analyst revised earnings estimates upward for fiscal 2026, with the Zacks Consensus Estimate at $12.92 per share and an average earnings surprise of +2.2%.
IQV
IQVIA Holdings Inc. · NYSE
Sign up free to see this.
Mkt Cap
$46B
Volume
64.2K
52W High
$282.98
52W Low
$154.50
PE Ratio
33.4
Avg Vol
1.5M
As of 10/23/26
Div Yield
—
Beta
0.72
As of 10/23/26
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about IQV?
Latest news
News ›Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $IQV · 0 threads
Sign in to post on $IQV
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.